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ABSTRACT 
 
Flexible polyurethane foam made from diphenylmethane-4,4’-diisocyanate (MDI) may con-
tain a few ppm of residual monomer. As this foam is used in consumer articles like uphol-
stered furniture and bed mattresses, the question arises if the residual monomer can result in 
consumer exposure and risk to consumer health. Integral skin polyurethane foam used for 
steering wheels and armrests and flexible polyurethane foam were analyzed for extractable 
MDI. The latter was also investigated with respect to migration and evaporation of MDI. 
There was no migration or evaporation of MDI detected. Against the experimental design and 
the corresponding detection limits less than 5.4 ng MDI per m³ air in the test chamber and a 
migration rate below 9 ng/cm² per day was found under simulated worst-case conditions (up 
to 10 ppm MDI in the flexible foam). For exposure by inhalation, these findings were com-
pared to the German MAK value for MDI in air, the US EPA Reference Concentration and 
the NOAEC for respiratory tract irritation. For dermal exposure, the findings were compared 
against a derived No Expected Sensitization Induction Level (NESIL) for allergic contact 
dermatitis in man. As a result, polyurethanes containing up to 24 ppm extractable MDI do not 
pose a critical toxicological risk to consumers. Whether higher contents are acceptable de-
pends on the result of migration and evaporation tests.  
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INTRODUCTION 
Flexible polyurethane foam may be 
produced by the reaction of diphenyl-
methane-diisocyanate (MDI, CAS-No. 101-
68-8) with polyetherols and/or polyesterols. 
For the reaction different additives are re-
quired, e. g. tertiary amines as catalysts, 
silicones-surfactants and water as blowing 
agent. Flexible foams are used in bed mat-
tresses and upholstered furniture, integral 
skin foam is used for example for steering 
wheels of cars and armrests of office chairs. 
The isocyanate reacts with OH-groups 
from alcohols, NH-groups, water, urethane-
groups and urea-groups to form urethanes, 
ureas, allophanates and biurets (Saunders 
and Frisch, 1967). The reaction of isocy-
anate with water liberates a primary, aro-
matic amine as an intermediate, which will 
instantaneously react further with another 
isocyanate-group. Amines are much more 
reactive to isocyanates than are alcohols 
and water (Mormann et al., 2006). 
With respect to consumer risk the ques-
tion is whether residual monomeric MDI in 
the polyurethane results in exposure. This is 
of interest as MDI is a known respiratory 
sensitizer, and occasional cases of skin sen-
sitization have been reportet (European 
Communities, 2005).  
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Several investigators have already 
looked for residual NCO groups or residual 
monomeric diisocyanate in polyurethanes 
using different analytical methods. FTIR 
has been used for the detection of NCO-
groups in polyurethanes (Cole and Ghe-
luwe, 1987). A distinction between NCO-
groups belonging to free, unreacted MDI 
and those belonging to the polymer-chain is 
not possible by FTIR-spectroscopy. Conte 
and Cossi (1981) and Jedrzejczak and 
Gaind (1993) investigated residual toluene 
diisocyanate (TDI) in a flexible foam via 
gas chromatography (GC). Using GC, it has 
to borne in mind that above 200 °C poly-
urethanes start thermolytic cleavage releas-
ing the isocyanate (Dick et al., 2001). Duff 
and Maciel (1991) followed the reaction of 
NCO-groups in an MDI-based polyurethane 
by 15N- and 13C- CP/MAS NMR.  
In our experiments the content of c MDI 
in polyurethanes was investigated in com-
bination with potential release via direct 
migration and evaporation. With respect to 
the purpose of this investigation, cold-cure 
moulded flexible foam can be regarded as a 
worst-case for the following reasons: 1) 
Other types of MDI-based foams are proc-
essed at higher temperatures a more com-
plete reaction of MDI, and 2) In comparison 
to integral foam with a skin-like surface 
(e. g. steering wheels), flexible foam has an 
open-cell-structure facilitating evaporation 
of any residual MDI, which should be de-
tectable in the surrounding air. 
 
MATERIALS AND METHODS 
The tests were run with a five days old 
MDI-based cold-cure flexible foam with a 
foam-index of 100 (molar ratio NCO-
groups : NCO-reactive groups = 1). For the 
extraction, toluene (for UV/VIS-spectro-
scopy, Riedel de Haen) and, as an alterna-
tive, ethyl acetate (for UV-spectroscopy, 
Riedel de Haen) were used. The MDI was 
derivatized with 1-(2-pyridyl)piperazine 
(PP), which was added to the toluene (1.17 
g/L) and the ethyl acetate (0.80 g/L, fresh 
solution!) respectively. The foam cushions 
investigated were produced from the raw 
materials (MDI and polyol with additives) 
either by hand mixing (stirring for 10 sec., 
samples “H”) or with a high-pressure mix-
ing-head machine (Puromat 80, pressure 
130-160 bar; samples “M”). 
 
Solvent extraction of the foam 
About 5 g foam (10 cm x 10 cm x 1 cm) 
was cut from the surface and from the mid-
dle of the cushion (size of cushion: 40 cm x 
40 cm x 10 cm, density 30 g/L) and 
weighed (accuracy ± 0.5 mg). The foam 
samples were cut into four pieces, put into a 
600 mL beaker and after adding 200 mL of 
the derivatizing solvent, squeezed and ex-
panded 30 times (duration approx. 2-3 min), 
using a clean 400 mL beaker as a plunger. 
The derivatizing solution was decanted; the 
process was repeated two times with 
140 mL derivatization solution. The com-
bined extracts were evaporated to dryness, 
the residue was taken up in 2 mL solvent 
(acetonitrile: dimethylformamide = 9 : 1). 
20 µL of this solution were injected into the 
injection-port of the high performance liq-
uid chromatograph (HPLC) MDI-deri-
vatives were detected with an UV/VIS-
detector (254 nm). Due to extractable UV-
active impurities causing a background 
noise, the detection limit was 1 µg MDI per 
g foam. 
 
Detection of MDI in air 
For the measurement of air extractable 
MDI, the foam cushion was placed in a 
dynamic fatigue test chamber (volume of 
chamber 400 L, volume of foam about 
16 L, T = 40 °C, 50 % rel. humidity) to-
gether with two MDI-sampling-devices 
consisting of an PP-coated glass-fibre filter 
fixed in a cassette, connected to a suction-
pump with a flow of 120 L/h. The design is 
shown in Figure 1. The advantage of the 
selected kind of chamber is the perfect 
simulation of normal use, where polyure-
thane foam is iteratively compressed and 
released, thus creating an air-exchange in 
the foam which may increase the release of 
volatile compounds. The chamber was 
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closed for 135 minutes while pumping air 
through the coated filters. 
 
 
Figure 1: MDI-based polyurethane foam in the 
dynamic fatigue test chamber with air sampling 
pumps (white arrows) and sampling filters  
(orange arrows) 
 
The cushion was periodically com-
pressed with 1.2 Hz. The compression-force 
varied between 150 and 750 N. Although 
there was no external air-exchange, the air 
was “purified” from MDI by passing the 
coated glass-fibre filters placed inside the 
chamber. By this way, 240 L air per hour 
were extracted from MDI. The MDI analy-
sis was performed according to OSHA 47 
(United States Occupational Safety and 
Health Administration, 1989), with some 
modifications. For analysis the filters were 
extracted with 2 mL solvent (acetonitrile : 
dimethylformamide = 9 : 1). The extract 
was concentrated to 1 mL, and 10 µL of the 
extract were injected into the HPLC. The 
detection limit was 2.9 ng MDI absolute 
which is equivalent to 5.4 ng/m³ air. Earlier 
experiments have shown that, during sam-
pling, no breakthrough of MDI is expected 
at an air-flow of 2 L/min and a sampling 
time of 2 h. 
 
Migration of MDI 
One foam sample was used to check 
MDI can be extracted by direct contact. 
Three glassfibre filters, coated with 1-(2-
pyridyl)piperazine (PP) with a diameter of 
were placed in contact with flexible foam 
pieces on both sides for 5 days. This sand-
wich–construction was compressed to 75 % 
of the original height. The residual MDI in 
the foam was analyzed by extraction with 
ethyl acetate and derivatization with PP as 
described above. In addition, the filters 
were extracted and analyzed as described 
above. In this case the detection limit was 
1 µg MDI per filter due to the background 
noise (i. e. detection limit 1 µg/22.68 cm²).  
 
HPLC analysis 
MDI-PP derivatives from foam extracts 
or the coated glass-fibre filter extracts were 
quantified by HPLC-UV. Instrument: Spec-
tra-Physics 8800. Column: Nucleosil 7 C-
18, ET 250/8/4 (Macherey Nagel). Eluent: 
acetonitrile/water (50/50) with 2.5 g tri-
ethylamine and 0.77 g ammonium-acetate 
per litre, pH = 6.3 (adjusted with acetic 
acid). Flow: 1.5 mL / min. Detector: UV-
VIS 254 nm fixed. 
 
RESULTS 
The results of the foam extraction tests 
are summarized in Table 1. No detectable 
amounts of MDI could be found in the air-
samples, with a detection-limit of 
5.4 ng/m³. All chromatograms showed 
peaks of residual, unreacted derivatizing 
reagent.  
The foam used for the contact migra-
tion-tests contained 3.15 ppm extractable 
MDI in the centre of the sample (arithmetic 
mean from 4 measurements: 3.1, 3.1, 3.2 
and 3.2 ppm, extraction with ethyl acetate). 
There was no MDI-derivative detectable in 
the filter extracts which had been in contact 
with both sides of the foam for 5 days at 
22 °C. Therefore, the migration of MDI 
over 5 days is less than 1 µg/22.68 cm² = 
44 ng/cm² or, continuous migration over 
time assumed, less than 9 ng/m³ per day.  
 
EXCLI Journal 2009;8:58-65  ISSN 1611-2156 
Received: March 2, 2009, accepted: March 8, 2009, published: March 10, 2009 
 
61 
Table 1: Extractable amounts of MDI; “H”: 
hand-mix flexible foam; “M”: machine flexible 
foam; I: integral skin foam 
Sample Solvent 
MDI 
extracted 
(ppm) 
H-surface-01 toluene 1 
H-surface-02 ethyl acetate 8 
H-surface-03 ethyl acetate 7 
H-center-01 toluene 2 
H-center-02 ethyl acetate 6 
H-center-03 ethyl acetate 3 
M-surface-01 toluene 3 
M-surface-02 ethyl acetate 14 
M-center-01 toluene 2 
M-center-02 ethyl acetate 5 
I-01 ethyl acetate < 1 
I-02 ethyl acetate < 1 
 
DISCUSSION 
Analytical findings 
The available data suggest that during 
the manufacturing of MDI based flexible 
foam trace amounts of MDI can remain in 
the polymer matrix. Using organic solvents 
it is possible to mobilize and extract resid-
ual MDI. By using ethyl acetate as solvent, 
slightly higher amounts were detected than 
using toluene, although the differences are 
neither consistent nor very large. MDI is 
known to react rapidly with water (Yakabe 
et al., 1999). The data generated in this pro-
ject suggest that this reaction does not occur 
as long as MDI is physically bound and 
protected in hydrophobic regions of the 
polymer matrix. This can be taken as evi-
dence that diffusion of water into the hy-
drophobic regions of the foam matrix is 
very limited. In addition, these results dem-
onstrate that diffusion of such physically 
bound MDI out of the polymer matrix does 
also not occur in practice. Integral skin 
foam shows lower amounts of residual, 
extractable MDI. Although the difference in 
MDI concentration between the surface and 
the centre of the foam is not high, there is 
an explanation for that finding. During cur-
ing the centre of the cushion has a higher 
temperature (about 120 °C) than the surface 
(about 60 °C), ensuring a more complete 
reaction of the MDI. However, as the data 
generated are around the detection limit of 
the method, the differences observed may 
be attributable to statistical noise. There-
fore, any differences observable between 
foam types, solvent and location of the 
sample should be regarded with caution.  
In the dynamic fatigue test, the foam 
was periodically compressed. This, as well 
as a temperature of 40 °C is a worst-case 
approach when compared to real life situa-
tions. However, an air-exchange rate of 
0.6 h-1 and a loading of 0.016 m³ foam per 
0.4 m³ space are not unlikely to be found in 
real life. The model room has a volume of 
17.4 m³, an air exchange rate of 0.5 h-1 and 
a temperature of 23 °C (ENV 13419-
1:1999, annex B).  
The non-detectability of MDI in the 
chamber air triggers the question whether 
the experimental set-up was appropriate at 
all. First, although not completely congru-
ent to the climate chamber defined by the 
EN 13419 standards, it seems unlikely that 
in normal sleeping rooms MDI emitted 
from polyurethane foam would reach con-
centrations that were not achievable in our 
test chamber. Second, our findings are con-
gruent to the findings of Hugo et al. (2000); 
they demonstrated that toluene diisocyanate 
(TDI) based flexible foam not only did not 
emit detectable amounts of TDI, but even 
filtered TDI out of contaminated air. TDI 
has a 100 times higher vapour pressure than 
MDI. 
 
Respiratory risk 
In the European Union, MDI is – be-
tween others – classified as harmful by in-
halation, risk of irreversible damage by 
repeated inhalation, a respiratory irritant, 
respiratory sensitizer and as carcinogen 
category 3 (European Communities, 2008). 
In the following, literature is cited where 
either diphenylmethane-4,4’-diisocyanate 
(MDI, CAS-no. 101-68-8) or polymeric 
diphenylmethane diisocyanate (pMDI, 
CAS-no. 9016-87-9) were used. pMDI con-
tains approximately 50 % MDI, and the two 
grades of “MDI” are regarded as being 
EXCLI Journal 2009;8:58-65  ISSN 1611-2156 
Received: March 2, 2009, accepted: March 8, 2009, published: March 10, 2009 
 
62 
equivalent in terms of toxicity (Feron et al., 
2001; European Communities, 2005).  
In chronic inhalation studies, highly 
respirable MDI aerosols caused lung tumors 
in rats (Feron et al., 2001). However, these 
findings were regarded to be of low rele-
vance for man as MDI is most likely a non-
genotoxic carcinogen, acting primarily via a 
threshold mechanism (European Communi-
ties, 2005). Tumor formation was observed 
only at concentrations that were irritating to 
the respiratory tract (Feron et al., 2001). 
The same line of argumentation is presented 
by the MAK commission of the Deutsche 
Forschungsgemeinschaft, who has allocated 
MDI to the cancer category 4 (Deutsche 
Forschungsgemeinschaft, 2008a). This cate-
gory names substances where a non-
genotoxic mechanism predominates, and 
tumour-induction is not expected if the 
MAK-value is followed throughout 
(Deutsche Forschungsgemeinschaft, 2008b). 
Based on these judgements, it is justified to 
assume that a sufficient protection of con-
sumers against airway irritation is a suffi-
cient protection against cancer induction 
due to potential MDI-exposure. 
The irritation threshold of MDI is about 
0.5 mg/m³ in rats (Pauluhn, 2002) and 
0.05 – 0.1 mg/m³ in man (Deutsche For-
schungsgemeinschaft, 1992). MDI- induced 
respiratory tract irritation in Brown Norway 
rats follows Haber’s rule (C x t = constant) 
when concentrations of 3.4, 6.2, 12.7, 25.1 
or 58.1 mg/m³ were applied for 6 h, 3 h, 
1.5 h, 45 min or 23 min (Pauluhn, 2000, 
2002). In the scope of these experiments, 
about 180 mg/m³ x min was reported to be 
the acute irritant threshold of MDI in 
Brown Norway rats. A workplace exposure 
limit of 0.05 mg/m³ is regarded as protec-
tive against airway irritation (Deutsche For-
schungsgemeinschaft, 1992). 
MDI is a respiratory sensitizer. Cur-
rently, there is no international accepted 
test-guideline for the quantitative evaluation 
of the respiratory tract sensitization hazard 
available, and the derivation of “safe” lev-
els is difficult and open to challenging dis-
cussions (European Chemicals Agency, 
2008a). Pauluhn proposed to use the Brown 
Norway rat as model for MDI-induced oc-
cupational asthma (Pauluhn, 2005). With 
this animal model, he demonstrated an 
elicitation threshold of 81 mg MDI/m³ x min 
in repeatedly challenged, “asthmatic” rats 
(Pauluhn, 2008). Based on this result, he 
derived a threshold concentration of 
0.006 mg MDI/m³ for 8 h for asthmatic 
human beings. For nonsensitized subjects, 
an 8 h time weighted average threshold of 
0.13 mg/m³ was derived (Pauluhn, 2008). 
This is in reasonable agreement with the 
MAK evaluation, where it is said that for 
the induction of respiratory hyperrespon-
siveness in workers, concentrations above 
0.2 mg MDI/m³ or intensive skin contact 
seem to be important, but 0.05 mg MDI/m³ 
seem to be protective (Deutsche For-
schungsgemeinschaft, 1992). In summary, 
0.05 mg/m³ are deemed to be protective 
with respect to airway irritation and sensiti-
zation at the workplace. To derive a safe 
level for the general population, we propose 
a factor of three to extent the results to 24 h 
exposure and a factor of 7 d/5 d for perma-
nent exposure; together, this is approxi-
mately a factor of 5. If a threshold value 
from animal experiments is derived, a fur-
ther factor of 10 is the default assumption 
for intra-human variability for the general 
population, whereas 5 is the default factor 
for workforces. (European Chemicals 
Agency, 2008b). That means, the default 
factor for workforce to general population 
extrapolation is 2. Based on the German 
MAK value, a threshold of 50 µg/m³ : 
~5 : 2 = 5 µg/m³ would result for the gen-
eral population. However, as some users of 
polyurethane foam are likely to be asthmat-
ics, the according threshold of 8 µg/m³ for 
the workplace derived by Pauluhn (2008), 
based on studies in Brown Norway rats, 
seems to be a more appropriate starting 
point. If the time factor of 5 (workplace to 
continuous exposure) and the worker-to-
consumer factor of 2 are applied, a thresh-
old of 800 ng/m³ results, slightly higher 
than the value of the US EPA Reference 
Concentration, which is 600 ng/m³ (United 
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States Environmental Protection Agency, 
1998). Therefore, we regard the Reference 
Concentration of 600 ng/m³ as being a suf-
ficient conservative threshold for the gen-
eral population with respect to respiratory 
tract irritation, sensitization and cancer. The 
RfC is more than 100 times higher than the 
derived maximum chamber concentration in 
our test (5.4 ng/m³). 
 
Dermal risk 
The induction of dermal sensitization is 
regarded to be the most critical endpoint 
with respect to dermal exposure to MDI. In 
the local lymph node assay (LLNA), the 
EC3-value for MDI was established as 
0.08 % MDI in acetone-olive oil (Selgrade 
et al, 2006). For risk evaluation, a proce-
dure proposed by Safford (2008) is used. 
Safford proposes to calculate the human No 
Expected Sensitization Induction Level 
(NESIL) based on the EC3 (in µg/cm²) 
value first:  
 
log10(NESIL) = log10 (EC3) * 1.16 – 0.64 
 
and then to devide the result by a safety 
factor (SAF) to derive the Acceptable daily 
Exposure Level (AEL). For the total SAF, 
Safford proposes a factor of 10 for human 
variability, a factor of 3 for matrix effects 
and a factor of 3 to 10 for use variability. 
The matrix factor pays tribute to a potential 
adverse impact of the matrix (further irri-
tants, enhanced penetration due to carriers); 
the use of the variability factor pays atten-
tion to the fact that breached skin due to – 
for example – shaving or occlusion is ex-
posed. For the PU foam matrix, the matrix 
variability factor and the use variability 
factor can be set = 1; this is justified as the 
normally moisture sensitive MDI seems to 
be protected by the foam matrix, which 
indicates a kind of encapsulation. There-
fore, SAF = 10 is used. Following the algo-
rithms proposed by Safford (2008), the re-
sult is 
 
EC3(MDI) = 0.08 % = 20 µg/cm², => 
NESIL(MDI) = 7.4 µg/cm², 
and, with SAF = 10, 
AEL(MDI) = 740 ng/cm² per day. 
This level is much higher than the 
maximum migration of MDI out of the 
flexible foam (containing about 3 ppm ex-
tractable MDI), which was calculated to be 
below 44 ng/cm² over five days or – con-
tinuous migration assumed – 9 ng/cm² per 
day. The approach chosen still is conserva-
tive as it is developed to be used for cos-
metics with intended repeated skin contact 
(Safford, 2008); the foam contains only 
accidentially residual, extractable MDI with 
a non-measurable migration. Additionally, 
flexible foam is usually covered by textiles 
that should also represent some barrier for 
migration.  
 
CONCLUSION 
As the open cell structured flexible 
polyurethane foam should be most critical 
concerning emission and migration of MDI, 
conclusions drawn from our test results can 
be extrapolated to other kinds of polyure-
thanes. A foam containing about 5 ppm 
extractable MDI gave reason to less than 
5.4 ng/m³ MDI in the test chamber air. This 
is well below the RfC of 600 ng/m³.  
Polyurethane containing about 3 ppm 
extractable MDI gave reason to a migration 
of less than 9 ng/cm² per day, which is well 
below the AEL of 740 ng/cm².  
Higher amounts of extractable MDI in 
polyurethanes might be acceptable with 
respect to consumer risk. Although it is not 
clear whether or not migration and evapora-
tion follow Fick’s law of diffusion – as it is 
unclear where the MDI is located inside the 
foam matrix and how it is bound – a content 
of 24 ppm seems to be acceptable. In case 
of linear dependence on the extractable 
amount, the expected exposure against MDI 
is at least ten times below the RfC and the 
AEL.  
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